Friday, April 3, 2026
Volume:
42
Issue:
4
Abstract:
On March 19, 2026, the United States (U.S.) Department of Justice (DOJ) announced a resolution of a transnational corruption investigation into Balt SAS (Balt), a medical device company headquartered in France, concerning an alleged scheme to pay bribes to a physician official who acted in a senior position of a state-owned public hospital in France, in violation of the Foreign Corrupt Practices Act (FCPA).